Dr. Guillermo A. Quiceno, MD

Dr. Quiceno practices at The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical.

Dr. Quiceno's NPI, 1487621330, was assigned on February 28, 2006. Dr. Quiceno graduated from Universidad CES in 1993. Dr. Quiceno's Texas license number on file is L2571.

Dr. Quiceno's primary practice is The University of Tennessee Medical Center, at 1924 Alcoa Highway, Knoxville, TN 37920 in Knox County. The practice phone is (865) 305-9000.

Dr. Quiceno's primary practice is The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical. Dr. Quiceno is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is UT Internal Medicine - Pellissippi. Dmand AI also links Dr. Quiceno to 2 more medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quiceno practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Quiceno's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Quiceno is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Quiceno's licenses on file in 3 states: Texas, Tennessee and Indiana.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Quiceno treats.

CMS data shows 66 Medicare services from Dr. Quiceno across 2 procedure codes in 2024, all of them office visits, for 67 Medicare patients. Medicare paid $4,309 for them.

CMS counts 67 Medicare patients who saw Dr. Quiceno in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Quiceno's median patient age at 63, with 72% women.

In 2024, Dr. Quiceno wrote 808 Medicare Part D claims for 174 patients. 85% of them were for generic drugs. CMS names the drug for 600 of them, across 23 drugs with 11 or more claims each, at $351,707 in total drug cost. In 2023, CMS named 1,865 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Quiceno for performance year 2024, reported through an alternative payment model (APM). Dr. Quiceno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quiceno as offering telehealth.

Dmand AI links Dr. Quiceno to 2 clinical trials. Conditions studied include Alzheimer Disease, Cognition Disorders and Neurocognitive Disorders. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Quiceno that name 2 trials.

CMS Open Payments shows 119 general payments to Dr. Quiceno from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Abbvie Inc. paid the most, $3,740. It also lists 2 research payments totaling $861 in 2016, naming 2 clinical trials.

Dr. Quiceno graduated from Universidad CES in 1993.

Dr. Quiceno is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.